Getinge AB

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000202624
SEK
190.65
1.95 (1.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
7,443.00
10,186.00
8,226.00
8,238.00
8,320.00
11,071.00
7,870.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,443.00
10,186.00
8,226.00
8,238.00
8,320.00
11,071.00
7,870.00
Raw Material Cost
4,098.00
5,689.00
4,692.00
4,571.00
4,528.00
6,375.00
4,593.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
135.00
164.00
163.00
147.00
170.00
173.00
152.00
Selling and Distribution Expenses
2,310.00
2,449.00
2,246.00
2,351.00
2,460.00
2,650.00
2,198.00
Other Expenses
17.40
32.10
12.30
17.90
13.10
22.40
15.00
Total Expenditure (Excl Depreciation)
6,717.00
8,623.00
7,224.00
7,248.00
7,289.00
9,422.00
7,093.00
Operating Profit (PBDIT) excl Other Income
726
1563
1002
990
1031
1649
777
Other Income
12.00
-153.00
-17.00
-94.00
-135.00
56.00
-438.00
Operating Profit (PBDIT)
1,222.00
1,951.00
1,500.00
1,412.00
1,442.00
2,315.00
861.00
Interest
135.00
164.00
163.00
147.00
170.00
173.00
152.00
Exceptional Items
-30.00
-39.00
-34.00
-27.00
-298.00
-622.00
-155.00
Gross Profit (PBDT)
3,345.00
4,497.00
3,534.00
3,667.00
3,792.00
4,696.00
3,277.00
Depreciation
484.00
541.00
515.00
516.00
546.00
610.00
522.00
Profit Before Tax
573.00
1,207.00
789.00
721.00
428.00
911.00
32.00
Tax
170.00
338.00
214.00
194.00
124.00
243.00
23.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
401.00
868.00
566.00
524.00
300.00
663.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
401.00
868.00
566.00
524.00
300.00
663.00
2.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.00
1.00
10.00
3.00
4.00
5.00
7.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
402.00
869.00
576.00
527.00
304.00
668.00
9.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.5
0.5
0.5
0.5
0.5
0.5
0.5
Reserves
30,975.00
29,430.00
29,175.00
28,823.00
30,553.00
33,005.00
30,258.00
Earnings per share (EPS)
1.47
3.19
2.08
1.92
1.1
2.44
0.01
Diluted Earnings per share
1.47
3.19
2.08
1.92
1.1
2.44
0.01
Operating Profit Margin (Excl OI)
9.75%
15.34%
12.18%
12.02%
12.39%
14.89%
9.87%
Gross Profit Margin
14.2%
17.16%
15.85%
15.02%
11.71%
13.74%
7.04%
PAT Margin
5.39%
8.52%
6.88%
6.36%
3.61%
5.99%
0.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -10.54% vs 10.74% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 32.24% vs -34.48% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -23.27% vs 28.63% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -20.59% vs 45.30% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Getinge AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
7,443.00
4,239.00
3,204.00
75.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,443.00
4,239.00
3,204.00
75.58%
Raw Material Cost
4,098.00
2,751.00
1,347.00
48.96%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
135.00
86.00
49.00
56.98%
Selling and Distribution Expenses
2,310.00
462.00
1,848.00
400.00%
Other Expenses
17.40
43.60
-26.20
-60.09%
Total Expenditure (Excl Depreciation)
6,717.00
3,735.00
2,982.00
79.84%
Operating Profit (PBDIT) excl Other Income
726.00
504.00
222.00
44.05%
Other Income
12.00
0.00
12.00
Operating Profit (PBDIT)
1,222.00
640.00
582.00
90.94%
Interest
135.00
86.00
49.00
56.98%
Exceptional Items
-30.00
-417.00
387.00
92.81%
Gross Profit (PBDT)
3,345.00
1,488.00
1,857.00
124.80%
Depreciation
484.00
136.00
348.00
255.88%
Profit Before Tax
573.00
1.00
572.00
57,200.00%
Tax
170.00
10.00
160.00
1,600.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
401.00
10.00
391.00
3,910.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
401.00
10.00
391.00
3,910.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.00
2.00
-1.00
-50.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
402.00
12.00
390.00
3,250.00%
Equity Capital
0
0
0.00
Face Value
0.50
0.50
0.00
Reserves
30,975.00
7,969.00
23,006.00
288.69%
Earnings per share (EPS)
1.47
0.03
1.44
4,800.00%
Diluted Earnings per share
1.47
0.03
1.44
4,800.00%
Operating Profit Margin (Excl OI)
9.75%
11.89%
0.00
-2.14%
Gross Profit Margin
14.20%
3.23%
0.00
10.97%
PAT Margin
5.39%
0.24%
0.00
5.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 744.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -26.93% vs 23.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -10.54% vs 10.74% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 40.20 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -53.74% vs 50.87% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 32.24% vs -34.48% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 121.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -42.49% vs 38.69% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -23.27% vs 28.63% in Mar 2025

Quarterly - Interest
Interest 13.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -17.68% vs 0.61% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -20.59% vs 45.30% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.75%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025